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Epidermal lineage commitment occurs when
multipotent stem cells are specified to three
lineages: the epidermis, the hair follicle, and
the sebaceous gland (SG). How and when a lin-
eage becomes specified remains unknown.
Here, we report the existence of a population
of unipotent progenitor cells that reside in the
SG and express the transcriptional repressor
Blimp1. Using cell-culture studies and genetic
lineage tracing, we demonstrate that Blimp1-
expressing cells are upstream from other
cells of the SG lineage. Blimp1 appears to gov-
ern cellular input into the gland since its loss
leads to elevated c-myc expression, aug-
mented cell proliferation, and SG hyperplasia.
Finally, BrdU labeling experiments demonstrate
that the SG defects associated with loss of
Blimp1 lead to enhanced bulge stem cell activ-
ity, suggesting that when normal SG homeo-
stasis is perturbed, multipotent stem cells in
the bulge can be mobilized to correct this
imbalance.
INTRODUCTION
Epidermal appendage formation involves an ordered set
of developmental processes beginning with lineage com-
mitment of undifferentiated stem cells, formation of a pop-
ulation of highly proliferative cells, and their subsequent
terminal differentiation (Alonso and Rosenfield, 2003;
Fuchs et al., 2001; Olivera-Martinez et al., 2004). These
stages are well delineated in the developing hair follicle,
where the highly proliferative cells, called matrix cells,are located at the base of the follicle in the hair bulb. The
matrix cells surround specialized mesenchymal cells (der-
mal papillae, DP), which are thought to provide a growth
stimulus. As matrix cells exit the cell cycle and move up-
ward and away from the DP, they differentiate to specify
a central hair shaft surrounded by its channel, or inner
root sheath (IRS) and companion layer, that guide the
shaft to its orifice at the skin surface. Exterior to these
cell layers is the outer root sheath (ORS), which is contig-
uouswith the interfollicular epidermis andcontains a reser-
voir of quiescent stem cells, referred to as the bulge. It has
been posited that when quiescent bulge stem cells be-
come activated at the start of each new hair cycle, they
exit the bulge niche and proliferate, moving downward
to produce the matrix cells (Oshima et al., 2001).
In contrast to the hair follicle, much less is known about
the formation of the sebaceous gland (SG), which buds
from the upper ORS as a terminally differentiating struc-
ture that resides above the bulge. Differentiated sebo-
cytes produce and secrete lipid-rich sebum into the hair
canal that empties out to the skin surface (Alonso and
Rosenfield, 2003; Stewart, 1992). Currently, two models,
not necessarily exclusive, have been proposed to suggest
howSG cells might arise. Themost widely held view is that
the bulge stem cells serve as the residence of the multipo-
tent progenitors which then migrate upward and differen-
tiate to generate the SG. This hypothesis is supported by
transplantation experiments where isolated bulge stem
cell populations are grafted to analyze cell fate plasticity
and are able to form epidermis, hair follicles, and SGs
(Blanpain et al., 2004; Morris et al., 2004; Oshima et al.,
2001; Taylor et al., 2000). Studies analyzing the rudimen-
tary follicle structures of hairless mutant mice further
support a role for bulge stem cells in sebocyte formation
(Panteleyev et al., 2000). It is possible that a population
of self-renewing progenitor cells reside within the SG it-
self, and that these progenitors maintain and generateCell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc. 597
the sebocytes that typify this gland. Fate mapping via ret-
roviral labeling of epithelial cells in vivo has provided some
evidence in support of this notion (Ghazizadeh and Taich-
man, 2001).
Elucidating the mechanisms that drive sebocyte devel-
opment is of fundamental importance not only to our un-
derstanding of stem cell biology and multipotency in the
skin but also of two major and as yet unsolved health con-
cerns, namely acne and sebaceous cancers. The end
point in sebocyte differentiation and lipid production is
likely to be controlled at least in part by the adipogenic
transcription factor PPARg, which is expressed in differ-
entiating sebocytes (Rosenfield et al., 1998). Although
PPARg null mice are not viable, PPARg null ES cells
have been found to contribute poorly to the SGs of chime-
ric mice, lending some supporting functional evidence to
this notion (Rosen et al., 1999). Most of the knowledge
regarding earlier steps in the process stem from overex-
pression or dominant-negative studies in mice. Over-
expression of c-Myc in the hair follicle induces SG hyper-
plasia at the expense of hair follicle differentiation (Arnold
and Watt, 2001; Bull et al., 2005; Waikel et al., 2001), and
alterations in hedgehog and Notch signaling proteins and
their effectors result in perturbations in SG development
(Allen et al., 2003; Niemann et al., 2003; Pan et al.,
2004). How these factors contribute to the SG lineage is
not yet clear.
In a screen to uncover new transcription factors in de-
veloping skin epithelium (to be published elsewhere), we
identified B lymphocyte-induced maturation protein 1
(Blimp1) as a potential regulator of epidermal appendage
development. Blimp1 is expressed in differentiating
plasma cells, where it acts to repress genes involved in
proliferation and promote differentiation (Lee et al., 2003;
Lin et al., 1997, 2000; Tunyaplin et al., 2004). In primordial
germ cells, Blimp1 regulates cell-lineage specification
(Ohinata et al., 2005; Vincent et al., 2005). Blimp1 per-
forms these functions by binding to DNA through its pro-
line-rich zinc finger domain and recruiting transcriptional
cofactors such as hGroucho, histone deacetylases, and
histone methyltransferases (Gyory et al., 2004; Lee et al.,
2003; Ren et al., 1999; Yu et al., 2000).
Given these interesting developmental roles of Blimp1,
we wondered whether Blimp1 might regulate the prolifer-
ation/differentiation of skin progenitor cells. In the course
of testing this hypothesis, we unexpectedly discovered
a unique population of Blimp1-expressing cells that reside
within the SG. Using conditional gene targeting, we show
that loss of Blimp1 results in larger SGs, with enhanced
pools of both slow-cycling progenitors and proliferative
cells, accompanied by increased c-Myc expression. Fi-
nally, although bulge cells do not express Blimp1, they
display signs of enhanced activity, which parallels the in-
creased flux of BrdU-labeled cells through the Blimp1-de-
ficient SGs. Taken together, our data suggest that the
population within the SG that are marked by Blimp1 are
unipotent progenitors, which control gland homeostasis
and govern the activity of bulge stem cells.598 Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc.RESULTS
Blimp1 Expression in a Novel SG Cell Population
In conducting microarray analyses, we identified Blimp1
(also known as PRDM1; Huang, 1994; Keller andManiatis,
1991) as a transcription factor whose increased expres-
sion correlated with late stages of embryonic skin mor-
phogenesis (data not shown). This finding was intriguing
given a prior developmental study on Blimp1, in which
immunohistochemical staining was noted in a wide variety
of embryonic tissues, including E18 surface ectoderm,
mesenchymal precursors of the dermal papillae (DP),
and inner root sheath (IRS) of developing whisker follicles
(Chang and Calame, 2002).
To explore Blimp1 expression in greater detail, we first
generated Abs against the 2nd Blimp1 exon. We also em-
ployed two BAC transgenic mouse lines that express
EGFP under the control of Blimp1’s regulatory elements
(Blimp1GFP) (Ohinata et al., 2005). The patterns of expres-
sion of Blimp1GFP and Blimp1 Ab staining corresponded
well, validating the efficacy of the anti-Blimp1 staining
patterns as faithful reflections of where the Blimp1 gene
was expressed. We subsequently used these tools inter-
changeably.
We first confirmed the embryonic expression of Blimp1
in nuclei of DP, suprabasal epidermis, and hair follicle IRS
(Figures 1A–1C). As hair follicle morphogenesis pro-
ceeded, Blimp1 extended to all three mature IRS layers,
and to cortical and medullar cells of the hair shaft, which
trails IRS differentiation (Figure S1). While Blimp1 corre-
lated with terminally differentiating cells of the epidermis
and hair follicles, it was conspicuously absent in prolifera-
tive compartments (Figures 1, S1, and S4). Blimp1was not
detected in E15.5 skin or earlier, i.e., at timeswhen embry-
onic epidermis exists as a single layer of multipotent
progenitor cells (Figure 1A).
Beginning late in embryonic development and extend-
ing into postnatal life, Blimp1+ nuclei appeared in the up-
per portion of maturing hair follicles (Figures 1C and 1D).
Blimp1GFP and anti-K14 IgG colabeled these interesting
cells (Figure 1E), and anti-Blimp1+ nuclei were contained
within K14+ cytoplasms of cells (Figure 1F). These findings
identified these cells as keratinocytes and were distinct
from previous reports of Blimp1 localization in the hair
follicle.
TheBlimp1+cells in the upper hair follicle appeared tobe
within or adjacent toSGs,which express the early differen-
tiation marker PPARg, known to govern a battery of genes
involved in lipid synthesis (Figures 1F–1H). The Blimp1+
cells were also not Oil Red O+, which stains later in the
maturation process as sebocytes become densely filled
with lipids (Figure 1I) (Rosenfield et al., 2002). Surprisingly,
the Blimp1+ keratinocytes were also negative for Ki67,
a nuclear marker of actively cycling keratinocytes, and b4
integrin, which marks the basal row of ORS, bulge, and
SG keratinocytes adhering to the surrounding basement
membrane (Figures 1J–1L). Blimp1 and the bulge marker
CD34 did not colocalize (Figure 1M). These cells were
Figure 1. Blimp1 Expression in the Sebaceous Gland
Immunofluorescence and/or epifluorescence microscopy was performed on skin sections of wild-type or Blimp1GFP transgenic mice at ages indi-
cated. Color-coding is according to secondary Abs or GFP and is marked on each frame. (H), (K), and (M) are confocal images. Schematic in (N) sum-
marizes the localization of Blimp1-expressing cells in the SG. Abbreviations: b4, b4 integrin; SG, sebaceous gland; ep, epidermis; DP, dermal papilla;
IRS, inner root sheath;HS,hair shaft, positive forBlimp1GFP (*);NB, newborn;Ad, adult;Bu, bulge (bracketed). ArrowsdenotedBlimp1+orBlimp1GFP+
cells in or near the orifice to the sebaceous gland. Note that patterns of anti-Blimp1 Ab and Blimp1GFP expression were comparable. Blimp1 was first
observed at E17.5, in the suprabasal epidermis and dermal papillae (DP). By birth, Blimp1 expression expanded to the IRS and to a site in upper outer
root sheath (ORS) where the sebaceous gland (SG) buds. Blimp1-expressing SG cells were K14/K5+, Ki67, ORO, PPARg, and CD34.also distinct from and resided externally to the K6-positive
companion layer, trichohyalin-positive IRS (AE15+) and
hair keratin-positive hair shaft (AE13+) (Figure S1).
Summarized in Figure 1N, these data reveal that Blimp1
is expressed by a group of keratinocytes that reside at or
near the bud site of the SG and possess molecular prop-
erties that distinguish them from the ORS, the bulge, and
the differentiated cells of the hair follicle. These cells arealso distinct from the proliferative and terminally differen-
tiating sebocytes that were previously thought to be the
sole constituents of the SG.
Blimp1 Regulates the Size and Activity of Glands
Composed of Sebocytes
Mice null for the Blimp1 gene die as early embryos
(Ohinata et al., 2005; Vincent et al., 2005; and referencesCell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc. 599
Figure 2. Blimp1 Regulates Sebocyte-
Containing Gland Size
K14-Cre:Blimp1fl/fl conditional knockout (cKO)
mice and organs are compared to wild-type
(WT) littermate controls.
(A and B) Images of hair coats of 2-month-old
mice.
(C) PCR genotype analyses.
(D) Anti-Blimp1 immunostaining of skin sec-
tions from6dayWTandBlimp1cKOmice. Sec-
tions were counterstained with hematoxylin.
(E–L) Data from 2-month-old WT and Blimp1
cKO mice. All SG analyses were performed in
telogen phase of the hair cycle.
(E and F) Brightfield images of Oil Red O and
hematoxylin-stained skin sections (E) and
wholemounts of Oil RedO-stained tail skins (F).
(G) Sebaceous gland measurements. The av-
erage area of 50 individual WT and cKO seba-
ceous glands was determined. n = 3 mice for
each genotype.
(H) Thin-layer chromatography of skin lipids.
CE, cholesterol esters; TG, triglycerides; C,
cholesterol.
(I) Real-time PCR of skin mRNAs tested for se-
bocyte markers (Mc5R, PPARg, and SCD3).
n = 4 for each genotype.
(J) Brightfield images of hematoxylin and eosin
staining of eyelid skin showing meibomian
glands.
(K) Brightfield images of preputial glands from
male mice. Abbreviations: Meibomian glands
(meib), epidermis (ep), and muscle (m).
(L) Measurements of meibomian and preputial
gland area. n = 4–5 for each genotype. Aster-
isks indicate significance, p < 0.05.therein). To determine Blimp1’s role in skin, we bred
Blimp1fl/fl mice (Ohinata et al., 2005) to transgenic mice
expressing the Cre recombinase under the control of the
K14 promoter, which is active by E15.5 in embryonic
skin keratinocytes, including multipotent skin progenitors
(Vasioukhin et al., 1999).
Neonatal mice genotypic for K14-Cre and Blimp1fl/fl al-
leles were born in the expected Mendelian numbers and
grew to normal size as adults (Figures 2A–2C). Real-time
PCR of epidermal mRNAs and anti-Blimp1 immunohisto-
chemistry verified that expression was conditionally ab-
lated as a consequence of the targeting event (data not
shown and Figure 2D). Blimp1 conditional knockout
(cKO) mice appeared indistinguishable from their wild-
type (wt) counterparts for their first 4 weeks of postnatal
life. Histological and biochemical studies revealed no
overt differences in the epidermis or hair follicles. The hairs
were comparable in types and lengths, and the hair cycle
appeared to be morphologically comparable over 2
months of age (Figure S2F and data not shown). As cKO
mice aged, however, their hair coat developed an oily ap-
pearance (Figure 2B). Hematoxylin and Oil Red O staining
revealed an enlargement of the SGs, and quantification of600 Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc.stained intact glands indicated that they were nearly 43
larger than normal (Figures 2E–2G).
The increased gland size was also reflected at the bio-
chemical level. Thin layer chromatography analyses of se-
bum lipids displayed an overall increase in cholesterol
esters, triglycerides, and cholesterol per unit area of
cKO skin (Figure 2H). Furthermore, real-time PCR indi-
cated a 5–103 increase in levels of mRNAs encoding
the sebocyte markers Mc5R, SCD3, and PPARg but not
the epidermal marker PPARa (Michalik et al., 2001)
(Figure 2I). Following the paradigm set for Blimp1-defi-
cient SGs, themeibomian glands of the eyelid and the pre-
putial glands of the male reproductive system were also
significantly enlarged in Blimp1 cKO animals (Figures
2J–2L). Taken together, these data provide compelling ev-
idence for an essential role for Blimp1 in controlling the
sizes and proportionate activity of different glands within
the body that contain sebocytes.
Finally, since skin lipids can contribute to epidermal bar-
rier function and differentiation (Dai and Segre, 2004) we
analyzed barrier formation and epidermal differentiation
(Figure S2). As judged by toluidine blue dye penetration as-
says, both wt and cKO embryos acquired full barrier
function between E16.5 and E17.5, and similarly wt and
Blimp1 cKO skins displayed indistinguishable patterns of
differentiation markers both in embryos (shown) and adult
mice (not shown). These data further substantiated that
the epidermis is not markedly affected by Blimp1 ablation,
and that the defects in lipids result from enlarged SG and
increased sebum production. The differences in PPARg
expression but not PPARa were also consistent with this
notion.
Blimp1 Regulates Cell Numbers within SGs
To determine if alterations in cell size or cell number
might underlie the increased size of sebocyte-containing
glands in Blimp1 cKO mice, we first counted nuclei within
the SGs of stained skin tissue sections. Based upon these
data, the average cell number per gland in cKO sections
was more than 50% larger (Figures 3A and 3B). Similar in-
creases were observed when PPARg was used to distin-
guish the differentiating gland cells (Figures 3C and 3D).
This was true for both adult and juvenile cKO glands, indi-
cating that the enhanced numbers of sebocytes preceded
the overt appearance of the excessively oily coat of the
cKO mice. Finally, when Ki67+ cells in the glands were
quantified, an increase of 53 was detected in cKO
skin (Figures 3E and 3F). Based upon these data, the
increase in sebocytes in Blimp1-deficient glands was
attributable to enhanced proliferation and expansion of
the proliferative sebocyte pool.
To monitor the proliferative residents and their fate
within the SG, we performed a BrdU pulse-chase experi-
ment on 2-month-old mice when their hair follicles were
in telogen (Figure S2F). Following a BrdU pulse, skin sec-
tions were analyzed for anti-BrdU labeling (green) and Oil
Red O counterstaining after 0.5, 4, or 15 days of chase
(Figures 3G–3I). These data indicated that significantly
more Blimp1-deficient SG cells were in the S phase of
the cell cycle than their wt counterparts. Correspondingly,
following the 4 day chase period, many of these BrdU-la-
beled cells were now also Oil Red O+, indicating that the
BrdU-labeled cells that were proliferating at 0.5 days
had now entered a terminal differentiation program to pro-
duce lipids. Consistent with the flux of proliferative cells
through and out of the gland, BrdU labeling was undetect-
able in the skins of either genotype after 15 days of chase.
Taken together, these findings establish that the defects
in Blimp1 cKO sebaceous glands arise from an initial
increase in Ki67+ proliferating SG cells. This results in ele-
vated numbers of PPARg+/Oil Red O+ differentiating se-
bocytes, which are eventually sloughed into the sebum
canal that exits at the skin surface.
Loss of Blimp1 Results in Misregulation of c-myc
in the Sebaceous Gland
Blimp1 cKO mice bore some phenotypic resemblance to
K14-c-myc-overexpressing transgenic mice, which also
displayed enlarged SGs (Arnold and Watt, 2001; Bull
et al., 2005). Given that Blimp1 represses c-myc promoteractivity in plasma cells (Lin et al., 1997; Yu et al., 2000), we
tested whether the phenotype in Blimp1 cKO SGs is di-
rectly attributable to c-myc misregulation.
Figure 3. Increased Cell number and Proliferation in Blimp1
Null Sebaceous Glands
All analyses of SG cell number and proliferation were performed on
telogen phase hair cycles in 2-month-old mice.
(A) Confocal images of tail whole-mount skin sections stained with the
nuclear dye TOPRO-3. Images were edited with Imaris software.
(B) Quantification of cell number in SGs. n = 3 for each genotype.
(C and D) Immunostaining with anti-PPARg Abs of skin sections from
2-month-old mice. Nuclei are counterstained with DAPI. Graph shows
quantification of PPARg-positive nuclei. n = 3 for each genotype.
(E and F) Immunostaining with anti-Ki67 Abs of skin sections from
2-month-old mice. Graph shows quantification of Ki67-positive nuclei
in individual SGs. n = 3 for each genotype.
(G) Epifluorescence of Oil Red O and anti-BrdU immunofluorescence
of 2-month-old mice pulsed with BrdU and chased for either 0.5 or 4
days. Arrows indicate nuclei within the Oil Red O+ cells, while arrow-
heads indicate nuclei outside of these cells.
(H) Quantification of SGs containing BrdU+ nuclei at indicated time
points.
(I) Quantification of the percentage of BrdU+/Oil Red O+ cells after 0.5,
4, and 15 days of chase. Asterisks indicate signifcance, p < 0.05.Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc. 601
Figure 4. c-Myc Expression Is Elevated
in Blimp1 cKO Skin
(A–D) Localization of c-Myc within SGs of P6
Blimp1GFP (A) or WT (B–D) mice. Skin sections
were labeled with Abs against c-Myc, K5, and/
or Ki67 or costained with Oil Red O as indi-
cated. Nuclei were counterstained with DAPI.
Arrowheads, Blimp1GFP-expressing cells; ar-
rows, c-Myc+ nuclei; asterisks, hair shaft (HS).
(E) Real-time PCR analysis of c-myc, L-myc,
and N-myc mRNAs in backskins of 2-month-
old mice. Asterisks indicate significance,
p < 0.05.
(F) Anti-c-Myc immunoblot analysis of 2-
month-old backskin proteins.
(G) Chromatin immunoprecipitation (IP) assays
were performed on keratinocytes expressing
a flag epitope-tagged, recombinant Blimp1
protein with anti-FLAG or control IgG antisera.
PCR analyses on the input or immunoprecipi-
tated fragments were performed using primers
encompassing a Blimp1 binding site previously
shown to bind Blimp1 (Primer-B) or primers
spanning an upstream region of the c-myc pro-
moter lacking Blimp1 binding sites (Primer-A).
(H and I) Immunostaining with anti-c-Myc Abs
and Oil Red O counterstain (H) or anti-K5 anti-
bodies (I). Arrows indicate c-Myc+ nuclei within
the SG. Arrowheads indicate c-Myc-positive
nuclei outside the gland. Asterisks denote hair
shaft.
(J) Quantification of the number of K5+ c-Myc+
cells in epidermis and hair follicles of 2-month-
old mice. Asterisks indicate significance,
p < 0.05.To identify which if any of the cells within the SG natu-
rally express c-Myc, we first colabeled Blimp1GFP P6
skin with anti-c-Myc Abs. Anti-c-Myc labeled nuclei of
cells within the basal and first suprabasal layers of epider-
mis and upper ORS, as well as a subset of Blimp1 cells
within the SG (Figures 4A and 4B). c-Myc+ SG cells were
uniformly K5+ and Oil Red O, but only a subset of them
labeled with anti-Ki67 (Figures 4B–4D). This pattern was
maintained as animals aged, showing c-Myc expression
in both proliferating and differentiating sebocytes.
If Blimp1 acts upstream of c-Myc to transcriptionally re-
press c-myc in undifferentiating cells of the SG, as it does
in plasma cells, then Blimp1 ablation should raise c-myc
expression levels. Real-time PCR revealed that mRNAs
encoding c-myc, but not N-myc or L-myc, were markedly
elevated by >5-fold in skin lacking Blimp1 (Figure 4E). Im-
munoblot analyses further confirmed that although c-Myc
was barely visible in protein extracts from wt skin, it was
readily detected in extracts from cKO skin (Figure 4F).
Finally, if Blimp1 directly regulates c-myc gene expression,
it shouldbind to thec-mycpromoter.Whenchromatin-pro-
teincomplexes fromflagepitope-tagged,Blimp1-express-
ing keratinocytes were immunoprecipitated with anti-flag
Abs, an 200 bp DNA fragment was pulled down that en-
compassed a Blimp1 binding site in the c-myc promoter
that hadpreviously beenshownbyelectrophoreticmobility602 Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc.assays to bind toBlimp1 protein in B plasma cells (Yu et al.,
2000) (Figure 4G). By contrast, PCR control primers corre-
sponding to an upstream c-myc promoter segment failed
to produce product in samples immunoprecipitated with
either control IgG or Flag Abs.
Finally, the number of anti-c-Myc-labeled cells was
markedly elevated in Blimp1-deficient SGs (Figures 4H
and 4I). As in wt glands, the majority of c-Myc+ cells in
cKO glands were Oil Red O and K5+. Further analyses
of K5+c-Myc+ cells in the skin revealed that while numbers
were unchanged in the epidermis, they were 63 higher
in the upper portion of cKO hair follicles compared to wt
(Figure 4J). When taken together with the phenotype of
K14-c-myc overexpression studies (Arnold and Watt,
2001; Bull et al., 2005; Waikel et al., 2001), our findings
suggest that Blimp1 governs the size of SGs by repressing
c-myc gene expression.
The Blimp1+ Cells Represent a Resident Population
of Sebocyte Progenitor Cells
To test whether the Blimp1-expressing cells in the SGs
might be resident progenitor cells of the sebaceous gland,
we began by culturing primary mouse keratinocytes
in vitro fromBlimp1GFP+ animals (Figure 5A). Blimp1GFP+
and Oil Red O+ cells adhered to a fibroblast feeder layer
and were independently dispersed throughout the dish
Figure 5. Blimp1+ SG Cells Are a Resident Population of Progenitor Cells with Properties of Unipotent Progenitor Cells
(A and B) Cell culture. Isolated Blimp1GFP keratinocytes are initially distinct from Oil Red O+ cells, but after day 5, sebocyte colonies composed of
GFP+ and Oil Red O+ cells were detected. Numbers of Blimp1GFP+ cells increased with passage. (B) FACS isolated Blimp1GFP+ and () cells were
cultured for 14 days and stained for Oil Red O. Oil Red O colonies were only found in cultures of GFP+ cells.
(C) Confocal projection of GFP and lipid dye (FM 4-64) epifluorescence from a whole mount of Blimp1GFP Bac transgenic tail skin.
(D) Schematic illustrating the genetic strategy to lineage-trace Blimp1+ SG cells in the skin.
(E and F) YFP epifluorence of tail skin whole mounts (left) stained a membrane dye (merge, right). Note YFP expression in the entire sebaceous gland
but exclusion of signal in the ORS and bulge.
(G–L) Backskin sections of R26-Pr-Stop-YFP or R26-Pr-YFP mice were immunostained with Abs against GFP and either PPARg (G, H, and L), Ki67
(H and J), or K5 (K).
(M) Quantification of the percentage of hair follicles containing either Blimp1+ (Blimp1GFP skin sections) or YFP+ (R26-Pr-YFP skin sections) cells that
colocalize with PPARg.
(N) Backskin sections of R26-Pr-YFP mice were immunostained with Abs against GFP and CD34. Note the colocalization of YFP with PPARg- and
Ki67-positive sebocytes and in the DP in R26-Pr-YFP mice. SG, Sebaceous gland; HS, hair shaft; DP, dermal papillae.Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc. 603
(Figure 5A). After 5 days in culture, the numbers of Oil
Red O+ cells had increased markedly. However, they
now appeared as colonies of sebocytes and 95% of
the Oil Red O+ colonies that developed were associated
with Blimp1GFP+ cells (Figures 5A and 5B). In addition,
sebocyte colony numbers increased upon subsequent
passage (data not shown), as did the numbers of GFP+
cells (Figure 5A), suggesting that the Blimp1+ cells are
able to proliferate and give rise to sebocytes in vitro.
To more rigorously analyze the ability of Blimp1GFP+
cells to act as sebocyte progenitors, we used fluores-
cence-activated cell sorting (FACS) to sort Blimp1GFP+
and GFP cells prior to culturing. As shown in Figure 5B,
while the GFP population gave rise to epidermal kerati-
nocytes, the GFP+ cells gave rise to colonies with distinct
morphology and with lipid-filled, Oil Red O+ cells. Similar
to the experiments using unsorted cells, the Oil Red O+
colonies contained GFP+ cells, The increased number of
Blimp1GFP+ cells in culture and with passage revealed
a capacity to self-renew, and their ability to form sebocyte
colonies underscored their action as progenitors for the
terminally differentiated cells of the SG.
To document the behavior of Blimp1+ cells as progeni-
tors in vivo, we next performed a genetic lineage tracing
experiment. For this purpose, we crossed Blimp1Cre-
BAC transgenic mice with mice expressing a transgene
containing a floxed-Stop-floxed sequence situated be-
tween a ubiquitously expressed Rosa26 (R26) promoter
and the yellow fluorescent protein (YFP) coding sequence
(Ohinata et al., 2005; Srinivas et al., 2001). By expressing
Cre recombinase under the control of the Blimp1 pro-
moter, the floxed stop codon at the Rosa26 locus should
be excised to activate YFP expression exclusively in
Blimp1+ cells and their descendents, irrespective of
Blimp1 promoter status (Figure 5D). If Blimp1+ cells are
a part of the sebocyte lineage, then their position along
the lineage should be readily assessed by analyzing the
expression of Rosa26-YFP within the gland.
To evaluate Rosa26-YFP expression in SGs, initially we
investigated whole, unfixed SGs of tail skins of Rosa26
promoter-Stop-YFP single transgenic adult mice (R26-
Pr-Stop-YFP), and Blimp1-Cre/Rosa26-floxed-stop-
floxed-YFP double transgenic mice (R26-Pr-YFP). After
treating skins with dispase, the isolated skin epithelium
was then counterstainedwith a lipid dye (Red), which inter-
calates into cell membranes. We then visualized the whole
mounts by double fluorescence confocal microscopy.
As expected, YFP was not detected in single transgenic
tail skins expressing either R26-Pr-Stop-YFP alone
(Figure 5E) or Blimp1-Cre alone (not shown). By contrast,
YFP was detected broadly in SG cells of R26-Pr-YFP tail
skin (Figure 5F). The expression of R26-Pr-YFP in glands
of these mice provided compelling evidence that most if
not all of the cells of the SG arise from the resident popula-
tion of Blimp1-expressing keratinocytes. To further verify
thatBlimp1-expressing SG cells contribute to both the dif-
ferentiating and proliferating sebocytes, we immuno-
stained R26-Pr-YFP skin sections with anti-PPARg and604 Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc.anti-Ki67 antibodies. Although Blimp1 was not detected in
either of these compartments (see Figure 1), YFP was de-
tected in both differentiated PPARg+ sebocytes (Figures
5G and 5I) and proliferative Ki67+ cells (Figures 5H and 5J).
To further analyze the contribution of Blimp1-express-
ing cells to the SG lineage, we examined newborn mice
in which the initial genesis of SGs occurs, as indicated
by PPARg in 50% of developing hair follicles. In newborn
hair follicles from R26-Pr-YFP skin sections, YFP+K5+
cells were seen in the upper hair follicle (Figure 5K), similar
to the expression of Blimp1 in newborn hair follicles
(Figure 1C). Additionally, in 98% of follicles displaying
PPARg+ cells, YFP exhibited coexpression (Figures 5L
and 5M). By contrast, Blimp1+ cells did not coexpress
PPARg (Figures 1G and 5M).
Based upon these collective analyses, we conclude that
the Blimp1+ population constitutes a pool of resident SG
progenitor cells. The expression of YFP in SG cells that
do not express the Blimp1 gene was in marked contrast
to YFP expression patterns in the epidermis, hair follicle,
and DP (Figures S3 and S4). These data confirmed that
the Blimp1+ cells in the epidermis and hair follicle reside
downstream from the proliferative compartment, which
remained negative for R26-Pr-YFP expression (Figures
S3 and S4). Finally, it was notable that R26-Pr-YFP ex-
pression was not detected in the CD34+ follicle bulge
(Figure 5N).
Increased Activity within the Bulge Stem Cell
Compartment of Blimp1 cKO Follicles
Although bulge stem cells were not Blimp1+ themselves
(see Figure 1E), they can reconstitute SGs in skin grafts
(Blanpain et al., 2004), leading us to wonder whether
theymight be the precursors of the Blimp1+ SG progenitor
cells. Moreover, if the Blimp1, label-retaining cells (LRCs)
of the bulge have the capacity to generate the Blimp1+
progenitors of the SG, then they might be expected to
be utilized more frequently when Blimp1 is conditionally
ablated. To test whether the activity of bulge cells is en-
hanced, we first examined proliferation in the bulge and
in the ORS bridge between the bulge and the SG, in 2-
month-old animals whose hair coats were in the telogen
phase of the hair cycle (Figure S2). As shown in the repre-
sentative images in Figure 6A, cKO follicles exhibited
more Ki67+ cells in the bulge and in the ORS segment
just above the bulge than their wt counterparts. By con-
trast, the numbers of cycling cells within the cKO and wt
epidermis were comparable, and no differences in epider-
mal differentiation were observed (Figure S2).
In response to short pulses of BrdU (5–12 hr), occa-
sional cells within the SG and ORS intersegment were la-
beled, but the bulge compartments were not (Figure 6B).
With longer BrdU pulses (36 hr), however, marked differ-
ences were observed in the CD34+ bulge cells of telogen
phase follicles of Blimp1 cKO mice (Figures 6C and 6D).
Most notable was an 83 increase in the number of
cKO follicles displaying BrdU-labeled cells within the
bulge compartment. Enhanced labeling was also seen in
Figure 6. Enhanced Activity of Bulge
Stem Cells in Blimp1 cKO Skin
(A) Increased Anti-Ki67 along anti-b4 ORS
above the bulge (Bu).
(B) After a 12 hr BrdU pulse, 2-month-old back-
skin samples were analyzed for anti-BrdU (ar-
rows in the SG, arrowhead nucleus in ORS
above the bulge) and anti-K5 immunofluores-
cence. Note: The anti-K5 chicken Ab used dis-
played atypically reduced staining in the bulge.
Asterisks denote hair shaft.
(C and D) After a 36 hr pulse, 2-month-old
backskin samples were analyzed for BrdU
and CD34. For quantification, n = 3 animals
each.
(E–I) At P6, matched WT and Blimp1 cKO litter-
mates were given a 72 hr pulse of BrdU and
were analyzed after a 28 day chase.
(E) FACS analysis of backskin cells shows that
the proportions of a6+/CD34+ bulge cells are
similar.
(F and G) Representative histogram (F) and
quantification (G) of the number of a6+/CD34+
cells with BrdU incorporation after BrdU
pulse-chase. n = 3 for each genotype. Asterisks
indicate significance, p < 0.05.
(H and I) Immunofluorescence was used to an-
alyze the numbers of BrdU (green, arrowheads)
label-retaining bulge cells (CD34+, red). For
quantification, n = 3 mice each.
(J and J0) GFP+ epifluorescence and anti-
Blimp1 immunofluorescence colocalize at the
SG base of sections of skin grafts derived
from a single K14-actinGFP bulge stem cell, af-
ter clonal expansion in vitro. (J0) shows DIC
phase-contrast.
(K–N) Samples from (H) revealed BrdU+CD34
LRCs above the CD34+ (red) cKO bulge (K).
This population at the SG base is positive for
K5 (L and N) and shows partial colocalization
with anti-c-Myc Abs (M). (N) shows quantifica-
tion of K5- and BrdU-positive cells at the SG
base in WT and cKOmice. n = 3 for each geno-
type. Asterisks indicate significance, p < 0.05.the cKO sebaceous gland and ORS bridge, as we had
already noted (Figures 4 and 6A).
To probe more deeply into the proliferative activity of
bulge cells in Blimp1 cKO skin, we administered extended
(3 day) BrdU pulses at either P6 or P28, then followed each
with 28 day chases and assayed for label retention by
FACS and immunofluorescence on the basis of their sur-
face expression of CD34 and a6 (Blanpain et al., 2004;
Trempus et al., 2003). As shown in Figure 6E, the patterns
of CD34 and a6 expression were similar in wt and cKO
skin cells, and no differences in bulge cell number or
size were detected. However, the % of BrdU+ bulge cells
was significantly reduced in cKO skin, and this was con-
firmed by immunofluorescence microscopy (Figures 6F–
6I). The inability of cKO bulge cells to retain label was
observed irrespective of whether the label retention was
analyzed in anagen (Figures 6E–6G) or telogen (Figures
6H and 6I). At both of these times, hyperproliferation
was prevalent in the cKO sebaceous glands, but not theepidermis (Figures 3 and S2). The dramatic reduction in
LRCs within the bulge correlated well with the observed
increase in proliferating ORS cells between the bulge
and SG.
Basedupon thesedata, the enhancedproliferation in the
cKO bulge and upper ORS segment seemed likely to be
a consequence of the defect in SG homeostasis caused
by Blimp1 deficiency. To directly address whether bulge
cells are capable of producing unipotent Blimp1+ sebocyte
progenitors,wefirst addressedwhether skingrafts derived
from the individual K14-GFP+ bulge stem cells harbor
GFP+ sebaceous gland progeny that are Blimp1 positive
(for method, see Blanpain et al., 2004). Immunofluores-
cence and phase-contrast microscopy revealed Blimp1
expression in all of the expected epithelial locations of
the graft. Most notably, Blimp1+ K14-GFP+ cells were de-
tected in the SG, and by phase-contrast, it was clear that
these cells resided at the mouth of the gland (arrowheads,
Figures 6Jand6J0). Thesedata support thehypothesis thatCell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc. 605
the Blimp+ unipotent progenitor cells within the SG are
descendants of the multipotent stem cells in the bulge.
Finally, although Blimp1 ablation resulted in increased
proliferative activity and loss of LRCs within the bulge,
the total number of LRCs was similar to that of wt mice
(Figure 6G). Closer inspection revealed the existence of
a new population of K5+ LRCs near or at the base of the
SG (arrowheads in Figure 6K). In contrast to bulge LRCs,
these LRCs lacked CD34 expression and instead often
showed labeling with anti-c-Myc Abs (Figures 6K–6M).
Quantification revealed that the loss in LRCs in the bulge
(Figures 6H and 6I) was accompanied by an equivalent
103 increase in follicles containing LRCs in this new res-
idence (Figure 6N).
DISCUSSION
Our data suggest that late in embryonic development,
near the birth of the animal, a population of Blimp1-ex-
pressing sebocyte progenitor cells is established to form
andmaintain the SG. Once the gland is formed, these pro-
genitors reside near the entrance of the gland to control its
homeostasis. Our genetic lineage-tracing experiments
and cell-culture studies demonstrate that these cells are
the progenitors of the cells within the gland, including
the proliferative, i.e., transiently amplifying, sebocytes
that subsequently differentiate to form the sebum-secret-
ing cells. By contrast, the Blimp1+ SG cells are negative for
both proliferation and differentiation markers. That said,
Blimp1+ SG cells can multiply in culture, suggesting that
these cells not only have the capacity to generate the
SG but they also possess the capacity to self-renew.
The Blimp1+ stem cells are biochemically distinct from
the multipotent stem cells of the bulge, which are negative
for Blimp1 (this paper) and positive for CD34, Tcf3, and
other markers (Blanpain et al., 2004; Morris et al., 2004;
Tumbar et al., 2004). Moreover, our lineage-tracing exper-
iments demonstrate that even though Blimp1+ cells are
able to generate the entire SG, they do not migrate out
of the gland to generate progeny within the epidermis or
hair follicle as R26-Pr-YFP-expressing cells were not de-
tected in proliferative compartments in these lineages.
Our results are intriguing in light of lineage-tracing exper-
iments in mice that were transduced with lacZ-marked
retroviral vectors (Ghazizadeh and Taichman, 2001). In
those studies, the authors noted chimeric lacZ expression
in clusters of epithelial cells within some pilosebaceous
units following five rounds of induced hair growth by dep-
ilation. In particular, it was notable that an appreciable
number of retroviral transduced pilosebaceous units in
these experiments displayed a lacZ-positive SG without
labeling other cellular compartments. These results can
best be explained by the existence of long-lived progeni-
tor populations in the gland. Our studies provide strong
support of this hypothesis and provide the first insights
into the molecular characteristics of these resident pro-
genitor cells.606 Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc.The increase in the numbers of highly proliferative cells
inBlimp1 null SGs supports a model whereby Blimp1 con-
trols the production of transiently proliferative cells of the
SG, which in turn differentiate to enhance the numbers
of sebum-producing sebocytes (Figure 7). Since Blimp1
is a transcriptional repressor expressed in the SG exclu-
sively by the sebocyte progenitors, we surmise that
Blimp1 governs some aspect of gene expression in these
cells that impacts directly on the flux of proliferating and
differentiating cells within the gland. There are several
ways in which Blimp1 might control this balance. Up-
stream, Blimp1 could regulate the contribution of bulge
stem cells to the SG by controlling a pathway involved in
communication between the bulge stem cell niche and
the SG. Downstream, Blimp1 could control the transition
from dormant progenitor cells into rapidly proliferating se-
bocytes by either repressing a key cell-cycle regulatory
gene(s) that might be essential for converting the dormant
progenitor cells into rapidly proliferating sebocytes or by
repressing the expression of a secreted factor that regu-
lates sebocyte proliferation through a nonautonomous
mechanism.
Our grafting studies with clonogenic bulge cells demon-
strate clearly that bulge stem cells can give rise to Blimp1+
SG progenitor cells. In addition, our pulse-chase experi-
ments demonstrate that bulge stem cells respond to the
absence of Blimp1 by enhancing their proliferation rate.
Since bulge cells do not express Blimp1, their activation
must be a reflection of enhanced stem cell usage by one
or more lineages. Of the three skin epithelial lineages,
the only one with obvious hyperplasia and enhanced flux
of proliferating and differentiating cells in Blimp1 cKO
skin was the SG lineage. Together, these experiments
provide compelling evidence that defects in the unipotent
progenitors of the SG can elicit the activity of the multipo-
tent stem cells of the bulge. This enhanced activity of the
Figure 7. Model for the Role of Blimp1 in Sebocyte Develop-
ment
Blimp1 is expressed in a population of cells that act as unipotent pre-
cursors for the proliferative sebocytes, which in turn differentiate into
lipid-containing sebocytes. Blimp1 represses c-Myc expression in
these sebocyte progenitors and regulates the size and number of cells
within the gland. Upstream, the multipotent bulge stem cells are sen-
sitive to the Blimp1-positive progenitors at the base of the gland and
can replenish them as necessary. Blimp1 null glands may resemble
a wound situation, as without Blimp1, the resident progenitor cells
are pushed down a distinct differentiation pathway.
stem cells inBlimp1 cKO hair follicles may be similar to the
contribution of bulge stem cells to the epidermis that only
occurs during wounding (Ito et al., 2005; Levy et al., 2005).
The fact that grafted bulge cells can produce Blimp1-pos-
itive cells supports the notion that in nonhomeostatic situ-
ations, bulge cells can form the sebaceous progenitor
cells. This finding may be relevant for human disorders
of the gland, like acne and cancers where the stem cells
may be contributing to disease pathogenesis when seba-
ceous development is aberrant.
Our data also support a downstream role for Blimp1 in
balancing SG homeostasis through the regulation of
c-myc transcription. Prior studies had shown that overex-
pression of c-myc in the epidermis results in sebaceous
hyperplasia as well as activation of the bulge stem cell
compartment (Arnold and Watt, 2001; Bull et al., 2005;
Waikel et al., 2001), and conversely, conditional deletion
of c-myc in these cells results in SG hypoplasia (Zanet
et al., 2005). Our studies document that c-myc gene ex-
pression is dramatically enhanced in the skin of Blimp1
cKO mice in K5+ cells surrounding Blimp1-deficient SGs
and suggest that Blimp1 acts upstream of c-Myc in the
SG. Thus, the regulation of c-Myc in progenitor cells
may specify the number of sebocytes within the gland. Al-
though c-Myc is known to promote proliferation by regu-
lating cell-cycle genes (http://www.myc-cancer-gene.
org/site/mycTargetDB.asp), enhanced c-Myc expression
in Blimp1 cKO SGs is also associated with an accumula-
tion of slowly cycling cells localized at the base of the
SG. Since many of these c-Myc-positive cells were not
actively cycling, we surmise that c-Myc may play addi-
tional roles besides regulating proliferation in the SG.
In closing, our studies illuminate the existence of a resi-
dent population of unipotent progenitor cells that exist
within the sebaceous glands of the skin. A transcription
factor, Blimp1, marks this population of cells and controls
sebaceous gland homeostasis. Upstream from these
Blimp1+ cells are mechanisms that control the activity of
multipotent stem cells. Our findings provide a significant
advance in our understanding of skin stem cells and
lineage determination, and they have important clinical
implications for therapeutic advances in the treatment of
glandular disorders, ranging from acne to cancers.
EXPERIMENTAL PROCEDURES
Generation of Mice, Grafts, and BrdU Incorporation
The generation of K14Cre, Blimp1-floxed, Blimp1Cre, and Blimp1-
eGFPmice were described previously (Ohinata et al., 2005; Vasioukhin
et al., 1999). Bulge stem cell grafts were performed as in Blanpain et al.
(2004). For 5-Bromo-20-deoxyuridine (BrdU) (Sigma-Aldrich) pulse-
chase experiments (Blanpain et al., 2004), mice were injected intraper-
itoneally with 50 mg/g BrdU (Sigma-Aldrich) and animals were then
sacrificed thereafter either directly or following a chase period.
FACS Isolation and Cell Culture
Bulge cell isolation and FACS analysis for CD34+ and a6+ cells was
performed as described (Blanpain et al., 2004). Isolation of epidermal
cells from Blimp1GFP mice was performed by incubating P4 back-
skins in trypsin overnight and scraping the epidermis from the under-lying dermis. After mincing and triturating the epidermis, neutralized
cell suspensions were strained with 70 mm pore cell filters. Single-
cell suspensions were subject to FACS isolation, and equal numbers
of cells were plated and cultured (Blanpain et al., 2004).
Histology and Immunofluorescence
Skins were embedded in OCT, frozen, sectioned, and fixed in 4%
formaldehyde. For paraffin sections, skins were incubated in 4% form-
aldehyde at 4C overnight, dehydrated with a series of increasing con-
centrations of ethanol and xylene, and embedded in paraffin. Paraffin
sections were rehydrated in decreasing concentrations of ethanol and
subjected to antigen unmasking in 10 mM Citrate, pH 6.0. Sections
were subjected to immunofluorescence microscopy as described
(Kaufman et al., 2003). For immunohistochemistry, HRP conjugate
secondary antibodies (Abs) were used followed by the HRP substrate,
diaminobenzidine. When applicable, the MOM Basic Kit (Vector Labo-
ratories) was used to prevent nonspecific binding of mouse monoclo-
nal Abs. Antibodies and dilutions are included in Supplemental Data.
Oil red O (ORO) staining was performed by incubating skin samples
in 0.18% ORO for 10 min, washing with PBS, and where indicated
counterstaining with hematoxylin.
Tail samples of hair follicles were treated with dispase overnight at
4C to separate skin epithelium from dermis. Hair follicle samples
weremounted in lipid dye FM 4-64 (1:1000, Molecular Probes), nuclear
dye, TOPRO-3 (1:1000, Molecular Probes) or stained with ORO.
For each type of analysis performed in this study, we assayed for
hair cycle by both histology and proliferation status as indicated by
BrdU incorporation during short pulses to confirm that the analyses
were performed in the same stage of the hair cycle.
Real-Time PCR
For real-time PCR (Rendl et al., 2005), total RNAs were isolated (Abso-
lutely RNA, Stratagene) from total skin, and equal amounts (1 mg) were
added to reverse transcriptase reaction mix (Stratagene) with oligo-
dT(12) as primer. RT-PCRs of RNA were used as negative controls,
and glyceraldehyde phosphate dehydrogenase (GAPDH) was used
to control for equal cDNA inputs. Real-time PCR was conducted
with a LightCycler system (Roche Diagnostics, Basel, Switzerland) us-
ing the LightCycle DNA master SYBR Green kit for 45 cycles. Light-
Cycle analysis software was used for quantifications. The number of
cycles needed to reach the crossing point for each sample was used
to calculate the amount of each product using the 2-DDCP method.
Levels of PCR product were expressed as a function of GAPDH.
Primer sequences are included in the Supplemental Experimental
Procedures.
Gland Area Measurements
Individual gland size was quantified using morphometric measure-
ments with Image J software. To analyze sebaceous glands, tail skin
was treated as above to remove dermal tissue, stained with ORO,
mounted, and analyzed. Preputial glands were dissected and meibo-
mian glands were analyzed from hematoxylin- and eosin-stained
sections of eyelid skin.
Statistics
All quantification data are mean ± SEM. To determine significance
between groups, comparisons were made using Student’s t tests.
Analyses of multiple groups were performed using One-Way ANOVA
with Bonferroni’s posttest with GraphPad Prism version for Macintosh
(GraphPad Software). For all statistical tests, the 0.05 level of confi-
dence was accepted for statistical significance.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and four figures and can be found with this article online at http://
www.cell.com/cgi/content/full/126/3/597/DC1/.Cell 126, 597–609, August 11, 2006 ª2006 Elsevier Inc. 607
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